Dual Bronchodilators and β-Blockade for Cardiovascular Risk in Chronic Obstructive Pulmonary Disease-Reply

JAMA Intern Med. 2018 May 1;178(5):731. doi: 10.1001/jamainternmed.2018.1450.

Authors

Meng-Ting Wang¹, Yun-Han Wang¹, Chen-Liang Tsai²

Affiliations

¹ School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, Republic of China.
² Division of Pulmonary and Critical Care, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.

PMID: 29801141
DOI: 10.1001/jamainternmed.2018.1450

No abstract available

Publication types

Comment

MeSH terms

Administration, Inhalation
Bronchodilator Agents
Cardiovascular Diseases*
Humans
Pulmonary Disease, Chronic Obstructive*
Quality Improvement
Risk Factors

Substances

Bronchodilator Agents